OB/GYN and Women's Health - Global Women's Health Academy

1-16 of 176

Understanding Crossover and Endpoints in ASCENT-03 and -04
Understanding Crossover and Endpoints in ASCENT-03 and -04
Project Oncology®
Understanding Crossover and Endpoints in ASCENT-03 and -04
- Jennifer Caudle, DO, FACOFP
- Neil M. Iyengar, MD
Improving Pain Management During Intrauterine Device Insertion
Improving Pain Management During Intrauterine Device Insertion
Advances in Women's Health
Improving Pain Management During Intrauterine Device Insertion
- Alexandria May, PharmD, BCPS
- Mitchell D. Creinin, MD
Managing Perimenopausal Bleeding with Evidence-Based Options
Managing Perimenopausal Bleeding with Evidence-Based Options
Advances in Women's Health
Managing Perimenopausal Bleeding with Evidence-Based Options
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
- Monica Christmas, MD
- Mary Jane Minkin, MD
Menopause Reimagined: The Role of Hormonal IUDs in Perimenopausal Care
Menopause Reimagined: The Role of Hormonal IUDs in Perimenopausal Care
Advances in Women's Health
Menopause Reimagined: The Role of Hormonal IUDs in Perimenopausal Care
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
- Mary Jane Minkin, MD
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Project Oncology®
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
- Ryan Quigley
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Project Oncology®
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Project Oncology®
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Predicting Breast Cancer Metastasis with Proteomics
Predicting Breast Cancer Metastasis with Proteomics
Project Oncology®
Predicting Breast Cancer Metastasis with Proteomics
Does BMI Matter in mBC Outcomes?
Does BMI Matter in mBC Outcomes?
Project Oncology®
Does BMI Matter in mBC Outcomes?
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Project Oncology®
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
On the Frontlines of Metastatic Breast Cancer
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
- Ashley Baker, MSN, PMHNP
- Nick McAndrew, MD, MSCE
Modern Approaches to Long-Term Metastatic Breast Cancer Care
Modern Approaches to Long-Term Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast Cancer
Modern Approaches to Long-Term Metastatic Breast Cancer Care
- Charles Turck, PharmD, BCPS, BCCCP
- Adam Brufsky, MD, PhD
New Insights into VKD: Exploring Maternal Obesity and Neonatal Vitamin K Status
New Insights into VKD: Exploring Maternal Obesity and Neonatal Vitamin K Status
Clinician's Roundtable
New Insights into VKD: Exploring Maternal Obesity and Neonatal Vitamin K Status
Preparing for Parenthood in Psoriasis: Closing Gaps in Family Planning Support
Preparing for Parenthood in Psoriasis: Closing Gaps in Family Planning Support
Global Women's Health Academy
Preparing for Parenthood in Psoriasis: Closing Gaps in Family Planning Support
Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
Project Oncology®
Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
- Pavani Chalasani, MD, MPH
- Timothy Yap, MBBS, PhD, FRCP
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
Project Oncology®
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
- Seth Wander, MD, PhD

Prev
1
2
3
…
10
11
Next

1/6